{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:02:27Z","timestamp":1791838947222,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23AR057789"],"award-info":[{"award-number":["K23AR057789"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54NS065768"],"award-info":[{"award-number":["U54NS065768"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000114"],"award-info":[{"award-number":["UL1TR000114"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1RR024131"],"award-info":[{"award-number":["UL1RR024131"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ymgme.2016.01.012","type":"journal-article","created":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T14:32:49Z","timestamp":1453991569000},"page":"427-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Elevated TNF-\u03b1 is associated with pain and physical disability in mucopolysaccharidosis types I, II, and VI"],"prefix":"10.1016","volume":"117","author":[{"given":"Lynda E.","family":"Polgreen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Vehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Rudser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Kunin-Batson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine Jarnes","family":"Utz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester B.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ymgme.2016.01.012_bb0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00004703-200608000-00002","article-title":"Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation","volume":"27","author":"Bjoraker","year":"2006","journal-title":"J. Dev. Behav. Pediatr."},{"issue":"9","key":"10.1016\/j.ymgme.2016.01.012_bb0010","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0002-9149(01)01999-3","article-title":"Coronary artery patency following long-term successful engraftment 14years after bone marrow transplantation in the Hurler syndrome","volume":"88","author":"Braunlin","year":"2001","journal-title":"Am. J. Cardiol."},{"issue":"7","key":"10.1016\/j.ymgme.2016.01.012_bb0015","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0002-9149(03)00909-3","article-title":"Usefulness of bone marrow transplantation in the Hurler syndrome","volume":"92","author":"Braunlin","year":"2003","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ymgme.2016.01.012_bb0020","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.amjcard.2006.02.047","article-title":"Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I","volume":"98","author":"Braunlin","year":"2006","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ymgme.2016.01.012_bb0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I","volume":"123","author":"Clarke","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ymgme.2016.01.012_bb0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10545-006-0490-x","article-title":"Restricted upper extremity range of motion in mucopolysaccharidosis type I: no response to one year of enzyme replacement therapy","volume":"30","author":"Cox-Brinkman","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2016.01.012_bb0035","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ymgme.2008.04.001","article-title":"Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase","volume":"94","author":"Harmatz","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.01.012_bb0040","article-title":"The effect of idursulfase on growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS)","volume":"14","author":"Jones","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2016.01.012_bb0045","article-title":"Orthopedic manifestations in patients with mucopolysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome Survey","volume":"2","author":"Link","year":"2010","journal-title":"Orthop. Rev. Pavia."},{"issue":"3","key":"10.1016\/j.ymgme.2016.01.012_bb0050","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10545-011-9317-5","article-title":"Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy","volume":"34","author":"Manara","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.01.012_bb0055","first-page":"1542","article-title":"Bone, joint and tooth development in mucopolysaccharidoses: relevance to therapeutic options","volume":"11","author":"Oussoren","year":"1812","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.ymgme.2016.01.012_bb0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ymgme.2007.01.011","article-title":"The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I","volume":"91","author":"Pastores","year":"2007","journal-title":"Mol. Genet. Metab."},{"issue":"12","key":"10.1016\/j.ymgme.2016.01.012_bb0065","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/bmt.2008.20","article-title":"Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation","volume":"41","author":"Polgreen","year":"2008","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.ymgme.2016.01.012_bb0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jocd.2013.03.004","article-title":"Low bone mineral content and challenges in interpretation of DXA in children with mucopolysaccharidosis types I, II, and VI","volume":"17","author":"Polgreen","year":"2014","journal-title":"J. Clin. Densitom."},{"issue":"2","key":"10.1016\/j.ymgme.2016.01.012_bb0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymgme.2013.11.013","article-title":"Effect of recombinant human growth hormone on changes in height, bone mineral density, and body composition over 1\u20132years in children with Hurler or Hunter syndrome","volume":"111","author":"Polgreen","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2016.01.012_bb0080","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10545-008-0878-x","article-title":"Neurological findings in Hunter disease: pathology and possible therapeutic effects reviewed","volume":"31","author":"Sawaf","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2016.01.012_bb0085","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2012.07.016","article-title":"An exploratory study of brain function and structure in mucopolysaccharidosis type I: long term observations following hematopoietic cell transplantation (HCT)","volume":"107","author":"Shapiro","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2016.01.012_bb0090","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/bmt.2009.31","article-title":"Short-term growth hormone treatment in children with Hurler syndrome after hematopoietic cell transplantation","volume":"44","author":"Polgreen","year":"2009","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.ymgme.2016.01.012_bb0095","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/BPO.0b013e31829abfe0","article-title":"Hip dysplasia in patients with Hurler syndrome (mucopolysaccharidosis type 1H)","volume":"33","author":"Thawrani","year":"2013","journal-title":"J. Pediatr. Orthop."},{"issue":"1","key":"10.1016\/j.ymgme.2016.01.012_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/PRM-2010-0105","article-title":"Bone density assessment in patients with mucopolysaccharidosis: a preliminary report from patients with MPS II and VI","volume":"3","author":"Fung","year":"2010","journal-title":"J. Pediatr. Rehabil. Med."},{"issue":"Suppl. 5","key":"10.1016\/j.ymgme.2016.01.012_bb0105","doi-asserted-by":"crossref","first-page":"v26","DOI":"10.1093\/rheumatology\/ker393","article-title":"Orthopaedic aspects of mucopolysaccharidoses","volume":"50","author":"White","year":"2011","journal-title":"Rheumatol. Oxf. Engl."},{"issue":"3","key":"10.1016\/j.ymgme.2016.01.012_bb0110","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/art.10168","article-title":"Targeting interleukin-1 in the treatment of rheumatoid arthritis","volume":"46","author":"Dayer","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"5 Pt 1","key":"10.1016\/j.ymgme.2016.01.012_bb0115","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000156510.96253.5A","article-title":"Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models","volume":"57","author":"Simonaro","year":"2005","journal-title":"Pediatr. Res."},{"issue":"9","key":"10.1016\/j.ymgme.2016.01.012_bb0120","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/labinvest.3780345","article-title":"Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses","volume":"81","author":"Simonaro","year":"2001","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"issue":"8","key":"10.1016\/j.ymgme.2016.01.012_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022447","article-title":"Anti-TNF-alpha therapy enhances the effects of enzyme replacement therapy in rats with mucopolysaccharidosis type VI","volume":"6","author":"Eliyahu","year":"2011","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.ymgme.2016.01.012_bb0130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1073\/pnas.0912937107","article-title":"Involvement of the Toll-like receptor 4 pathway and use of TNF-\u03b1 antagonists for treatment of the mucopolysaccharidoses","volume":"107","author":"Simonaro","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2016.01.012_bb0135","doi-asserted-by":"crossref","first-page":"e54459","DOI":"10.1371\/journal.pone.0054459","article-title":"Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses","volume":"8","author":"Schuchman","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.ymgme.2016.01.012_bb0140","doi-asserted-by":"crossref","first-page":"e100882","DOI":"10.1371\/journal.pone.0100882","article-title":"Dose responsive effects of subcutaneous pentosan polysulfate injection in mucopolysaccharidosis type VI rats and comparison to oral treatment","volume":"9","author":"Frohbergh","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.ymgme.2016.01.012_bb0145","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/labinvest.2011.7","article-title":"Arterial pathology in canine mucopolysaccharidosis-I and response to therapy","volume":"91","author":"Lyons","year":"2011","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"issue":"2","key":"10.1016\/j.ymgme.2016.01.012_bb0150","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ymgme.2013.11.001","article-title":"Carotid intima-media thickness is increased in patients with treated mucopolysaccharidosis types I and II, and correlates with arterial stiffness","volume":"111","author":"Wang","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.01.012_bb0155","series-title":"R: A Language and Environment for Statistical Computing [Internet]","author":"Team RDC","year":"2011"},{"issue":"7","key":"10.1016\/j.ymgme.2016.01.012_bb0160","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0945-053X(00)00108-6","article-title":"Osteopontin: a versatile regulator of inflammation and biomineralization","volume":"19","author":"Giachelli","year":"2000","journal-title":"Matrix Biol. J. Int. Soc. Matrix Biol."},{"issue":"1","key":"10.1016\/j.ymgme.2016.01.012_bb0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1947603511421502","article-title":"Osteopontin deficiency suppresses tumor necrosis factor-\u03b1-induced apoptosis in chondrocytes","volume":"3","author":"Yumoto","year":"2012","journal-title":"Cartilage"},{"issue":"2","key":"10.1016\/j.ymgme.2016.01.012_bb0170","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ymgme.2014.11.015","article-title":"Biomarkers of central nervous system inflammation in infantile and juvenile gangliosidoses","volume":"114","author":"Utz","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2016.01.012_bb0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/PRM-140285","article-title":"Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI","volume":"7","author":"Stevenson","year":"2014","journal-title":"J. Pediatr. Rehabil. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2016.01.012_bb0180","doi-asserted-by":"crossref","first-page":"E186","DOI":"10.1152\/ajpendo.00652.2013","article-title":"Distinct mechanisms of induction of hepatic growth hormone resistance by endogenous IL-6, TNF-\u03b1, and IL-1\u03b2","volume":"307","author":"Zhao","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719216300117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719216300117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T21:18:12Z","timestamp":1638652692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719216300117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1096719216300117"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2016.01.012","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated TNF-\u03b1 is associated with pain and physical disability in mucopolysaccharidosis types I, II, and VI","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2016.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}